Having been diagnosed with Young Onset Parkinson’s aged 34, fashion designer Genna Douglas was left isolated and confused about how to get on with her life. To make sure no one else suffers a similar fate, she has teamed up with Parkinson’s UK and clothing giant Next to create a range of products that are raising both money and awareness.
The ordinary task of doing the washing up one day would prove to be a huge moment for Genna Douglas, after she noticed her hand was not moving properly.
While on maternity leave having just had her second daughter, doctors originally thought the problem was a damaged nerve and she was placed on a course of medication to deal with it.
This wasn’t enough for Genna as she knew something still wasn’t right.
She eventually got through to a neurologist, who diagnosed her with Young Onset Parkinson’s. She was 34.
Genna told NR Times how stunned she was by her diagnosis.
“I was completely shocked,” she said. “I didn’t know anything about Parkinson’s because it’s not in my family. I’ve never even met anyone with it.
“I didn’t know where to start with my questions.
“My first concern was for my children, if I’m going to be around for them in the future.
“It was all a bit of a whirlwind and I didn’t ask everything I wanted to ask, so I walked away with a prescription and millions of questions.”
The lack of information around younger people with Parkinson’s was what Genna felt was most damaging.
“When I was diagnosed I felt really lonely, I felt like I didn’t know who I could talk to about it and I thought I was the only person my age that had Parkinson’s.
“All the information pointed to the older generation.”
Research suggests that Genna is far from alone in experiencing this isolation; with around 24 per cent of patients being told they were too young to have the disease according to Parkinson’s UK.
Meanwhile, 87 per cent of people with the condition have faced some form of discrimination or harassment, with this figure rising to 99 per cent among those aged 40 to 50.
Genna said: “To look at me, people would not realise that I have Parkinson’s a lot of the time because I don’t have an obvious tremor like most people do.
“It is not the only hidden disability, there are hundreds out there. Everyone has their own kind of struggles in life, if you see someone struggling, just be patient and be kind.”
Genna is passionate about addressing this stigma, and is taking action through her role as a fashion designer for clothing giant Next.
Having been at the company for 15 years, she is now helping raise money for Parkinson’s UK, the country’s biggest charity related to the disease.
Genna has helped to design a range of products that simply promote positivity and the ability to be yourself.
Launched just before World Parkinson’s Day, the t-shirts and tote bags feature bright designs and fun slogans, with 100 per cent of profits going to the charity.
Genna was keen to use the campaign to bring Young Onset Parkinson’s to the forefront of conversation and showing that it is not simply an age related condition.
“Anybody can get Parkinson’s, young or old, so we want to try and raise the awareness that you don’t just have to be an older gentleman to get it.
“On the T shirts themselves they say ‘if nothing else, be yourself’ and that’s really important for people with Parkinson’s, as they can struggle to open up to family and friends. I think the message of trying to be honest with people about how you’re feeling is really important.”
She is also hoping it will play a role in improving support for those who are diagnosed with Parkinson’s from a young age.
“I want to try and get the message out there that you can get Parkinson’s at any age and I’m working with Parkinon’s UK to try and make the support for younger people better and more tailored.
“The help needs to be more specific for people of a working age. I work, I’ve got kids and a mortgage, I’ve got different responsibilities to somebody who’s older and perhaps retired.
“I think it’s really important that the support is there for people like myself and also for people to talk about it because I wasn’t aware you could get it so young. I’m sure there’s lots of people that live with it that don’t even know they have it.”
Genna has never shied away from talking about Parkinson’s, even when it came to telling her two young daughters about it.
“I’ve never hidden it from them,” Genna said. “I’ve always spoken about it around them.
“Everybody has different symptoms so it’s very difficult to explain to young kids, but they do know that I have Parkinson’s and they do know that I struggle with my arm and I get tired.
“Because I do quite a bit of advocacy for Parkinson’s UK they hear about it all the time but it’s really hard to describe Parkinson’s and what condition is because to be honest I can’t describe it.”
This discussion around the disease is crucial for those living with it. The campaign between Next and Parkinson’s UK is a step in the right direction but Genna has more ideas to help younger Parkinson’s patients.
The charity’s future work will have a much broader outlook on the condition, with plans already being made to produce support packages tailored to patients of different ages and genders.
This will make sure no one goes through Parkinson’s alone, which is the kind of support Genna says she would have liked to have when she was diagnosed.
“I wish I had somebody that had said to me it’s not the end of the world, you need to live your life now enjoy it because you don’t know how fast it’s going to progress.
“No one can tell you that, you just need to make the most of what you’ve got.”
The Parkinson’s UK t-shirt range is available for purchase from the Next website.
£1m dedicated to MND research through 7 in 7 Challenge
A £1million fund has been created to lead new research into potential treatments for Motor Neurone Disease (MND) through the efforts of an iconic challenge by Kevin Sinfeld.
Kevin, director of rugby at Leeds Rhinos, raised over £2million through his 7 in 7 Challenge, inspired by his former team-mate and close friend Rob Burrow.
Rhinos legend Rob was diagnosed with MND in December 2019, and Kevin completed seven marathons in as many days to help boost badly-needed research into the condition.
Now, with £500,000 of the money raised through the 7 in 7 Challenge ring fenced for research, that sum has been matched by medical research charity LifeArc.
The move has created a £1million joint fund established by the MND Association and LifeArc, which will support research projects focused on developing new therapies or repurposing drugs already approved for use for other conditions.
“This is fantastic news and an amazing contribution from LifeArc,” says Kevin.
“When we set out to complete the 7 in 7 Challenge we hoped to raise awareness and funds to support the MND community but it is so wonderful to see the inspiration it has given people and organisations, like LifeArc, so they too can support the need for more research.
“Our hope, like that of everyone affected by this brutal disease including Rob, is that this money will make a real difference and help find the breakthrough we all desperately want.”
Researchers are now able to apply for a share of the funding, with the criteria that they will be expected to conclude their project within three years and be target driving with set milestones and a credible delivery plan – including a clear route to reach MND patients.
Dr Brian Dickie, director of research development at the MND Association says: “We are so grateful to LifeArc for this generous contribution and are looking forward to working with them to identify projects which have a real chance of making a difference to our community in the coming years.”
Melanie Lee, LifeArc’s chief executive, emphasised that the focus of the new funding is on boosting research around potential treatment options based on the latest understanding of the disease.
“The ambition around stimulating the search for new treatments fits with LifeArc’s approach over the last 25 years to translate early science into health care treatments or diagnostics that can transform patients’ lives,” she says.
“Our partnership with the MND Association is the latest in a series of strategic partnerships that maximise LifeArc’s expertise in translating strong discoveries from the lab into benefitting patients with conditions with few or no effective treatment options.”
What causes a stroke?
Over 100,000 people in the UK suffer a stroke each year, with there currently being around 1.2 million survivors living in the country.
Many people note that despite how common strokes are they remain unaware of what the actual causes of a stroke are.
Depending on which of the two types develops, causes and outcomes can differ.
What both have in common is they restrict blood flow to the brain. This leads to a reduction in the brain’s oxygen levels, which can cause tissue damage.
Here, NR Times breaks down why a stroke may occur and what risk factors there are behind each different type.
What are the different types of stroke?
There are two main types of strokes: ischaemic and hemorrhagic.
Ischemic strokes make up nearly 90 percent of all cases and they materialise when an artery which provides blood and oxygen to the brain becomes blocked.
A hemorrhagic stroke is much less common, but happens when an artery leading to the brain bursts and starts to leak blood around or in the brain.
Causes of an ischaemic stroke
The brain is only able to function properly when its arteries supply it with oxygen-rich blood, meaning any blockages can cause lasting damage.
With a lack of blood flow, the brain is unable to make enough energy to work. If this consists for more than a few minutes, brain cells will begin to die.
This is exactly what happens in an ischaemic stroke, but there are a range of reasons as to why these blockages develop.
One of the main causes is when the arteries around the head narrow, which makes it harder for the blood to pass through.
This can also lead to something called atherosclerosis, which is where substances in the blood (such as fat or cholesterol) stick to the sides of the arteries.
Blood can build up on these deposits, causing a further increase in pressure and a reduction to the brain’s oxygen supply.
There are a number of reasons for these blockages, with the most common ones being around a person’s lifestyle.
For example, smoking can increase the risk of a stroke by up to 50 percent.
This is because nicotine not only narrows the arteries, but it also makes the heart beat faster, causing an increase in blood pressure.
Excessive alcohol intake, obesity and high cholesterol levels are also all listed as major risk factors when it comes to ischaemic strokes.
Problems with the arteries around the heart can also lead to an ischaemic stroke.
Irregular heartbeats, heart attacks and other irregularities around this area can again limit the blood’s oxygen levels.
Causes of a hemorrhagic stroke
Hemorrhagic strokes are most common in people ages 45 to 70, but they affect a lot more younger people than an ischaemic stroke.
These are caused after the arteries around the brain burst and cause bleeding.
Depending on where the artery is can affect the outcome of the hemorrhagic stroke.
If the bleeding occurs within the brain, blood shooting out at high pressure can kill some cells.
Bleeding on the surface increases the pressure in the protective layer between the brain and the skull, potentially causing more cell loss.
This bleeding is normally caused by chronically high blood pressure. In many cases, the increased pressure can cause the arteries to expand and weaken, meaning a split in them is more likely to take place.
A rarer cause of hemorrhagic stroke is where the blood vessels around the brain are connected abnormally, causing further stress on the brain. These are congenital (present at birth) but the reason for their occurrence is currently unknown.
Again, the best way to reduce the risk of an hemorrhagic stroke is to make healthy lifestyle choices.
NHS pilots video service for epilepsy diagnoses
A new clinical video service which supports epilepsy diagnoses and management in the era of coronavirus and beyond has been launched in the UK.
vCreate Neuro allows registered patients and carers to share smartphone-recorded videos of potential seizures or unknown movements with their clinical team via a secure, NHS-trusted system.
The data and footage act as a visual aid to assist clinical teams with rapid precision diagnostics, creating a digitised clinical pathway that minimises the need for face-to-face clinic appointments and invasive tests.
The system is currently being piloted across Scotland and, following its initial success, across England including Great Ormond Street Hospital, Evelina London and Sheffield Children’s Hospital.
The system is available to families who are concerned that they, their child or loved one may be experiencing seizures or unexplained episodes including epilepsy.
Since May 2020, more than 2,000 families have shared over 5,000 videos with their clinical teams across the platform.
Dean MacLeod was referred to the service when her seven-year-old daughter, Olivia, began having unknown movements in May 2020.
Dean uploaded videos of Olivia during these episodes as Olivia’s seizures grew more frequent.
The videos were reviewed by Paediatric Neurology professionals at the Royal Hospital for Children, Glasgow, and, supported with telephone appointments, Olivia was diagnosed with a form of epilepsy and quickly started on treatment.
Speaking about her experience, Dean said: “I’ve found vCreate to be invaluable in Olivia’s journey since she started having seizures last summer.
“We live in a remote location on the Isle of Lewis, Scotland, and we have a very limited paediatric service on the Island. The service has made it easy to access the specialist clinical knowledge needed by sending recordings of various seizure events to the Paediatric Neurology team at Glasgow.
“Since the diagnosis, I have kept in regular contact with the clinical team through the platform, sending videos and typically receiving advice from a Consultant within 24 hours which is fantastic. Between the vCreate service and telephone discussions, our family have not needed to have face-to-face consultations which has been hugely beneficial during the pandemic.”
Professor. Sameer Zuberi, consultant paediatric neurologist at the Royal Hospital for Children, Glasgow, said: “vCreate Neuro has transformed how we use carer-recorded video in our service. We are diagnosing epilepsy more rapidly, preventing misdiagnosis and saving unnecessary investigations. Families feel in more control and better connected to the service.
During the Covid-19 pandemic, many people experiencing seizures and seizure-like episodes, including children, have been unable to see a clinician.
Create Neuro aims to help by empowering patients to use asynchronous video technology for self-management, reducing the need for physical appointments.
Founder Ben Moore said: “We’re passionate about family-forward care, and worked closely with clinical teams, patients and carers to develop the vCreate Neuro service.
“The system aims to improve patient care, reduce the number of clinic investigations – and resulting costs to the NHS – and digitise the patient pathway. We want families to be in control of their healthcare journey and have a direct link to their clinical team despite the pandemic restrictions.”
The vCreate platform has been independently assessed and approved by Information Governance teams in over 100 UK NHS Trusts.
Within the platform, a clinical database is available as a learning resource for clinicians to study seizure types, events, and other symptoms.
Brain injury4 weeks ago
‘I’m sorry for handling the steering wheel with buttered fingers’
Case management4 weeks ago
New case management business continues to grow
Brain injury4 weeks ago
Sleep problems ‘can be worse with mild TBI’
Neuropsychology3 weeks ago
Mental health issues ‘may stem from childhood cognitive problems’
Stroke2 weeks ago
Stroke Association launches long-term stroke/COVID study
Stroke2 weeks ago
Surviving stroke: the transition from hospital to home
Community rehab4 weeks ago
Finding a voice for Richie
Brain injury3 weeks ago
Impact of COVID-19 on brain to be investigated